Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
$4.76B |
| 2 |
Microsoft
MSFT
|
$1.4B |
| 3 |
NVIDIA
NVDA
|
$1.4B |
| 4 |
Amazon
AMZN
|
$1.22B |
| 5 |
Broadcom
AVGO
|
$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$139M |
| 5 |
Cadence Design Systems
CDNS
|
$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNST
3926
DELISTED
Pinstripes Holdings, Inc.
PNST
| $185K | ﹤0.01% |
240,931
-12,461
| -5% | -$9.56K |
|
3927
Xos
XOS
$19.8M
| $184K | ﹤0.01% |
40,438
+4,510
| +13% | +$20.5K |
|
3928
Oculis Holding
OCS
$903M
| $183K | ﹤0.01% |
14,944
| – | – |
|
3929
Quantum Corp
QMCO
$100M
| $183K | ﹤0.01% |
52,137
+1,218
| +2% | +$4.26K |
|
3930
SAB Biotherapeutics
SABS
$22.4M
| $182K | ﹤0.01% |
67,542
+8,127
| +14% | +$21.9K |
|
3931
BioXcel Therapeutics
BTAI
$59.4M
| $182K | ﹤0.01% |
18,628
+1,958
| +12% | +$19.1K |
|
3932
Connexa Sports Technologies
YYAI
$25.5M
| $182K | ﹤0.01% |
+19,558
| New | +$182K |
|
3933
US GoldMining
USGO
$118M
| $182K | ﹤0.01% |
22,529
+2,126
| +10% | +$17.1K |
|
3934
enGene Holdings
ENGN
$272M
| $182K | ﹤0.01% |
27,516
| – | – |
|
3935
bioAffinity Technologies
BIAF
$7.24M
| $181K | ﹤0.01% |
87,181
+17,581
| +25% | +$36.6K |
|
3936
TherapeuticsMD
TXMD
$12.5M
| $180K | ﹤0.01% |
108,333
+12,856
| +13% | +$21.3K |
|
3937
Urban One Class D
UONEK
$40.8M
| $180K | ﹤0.01% |
161,940
-20,945
| -11% | -$23.3K |
|
|
VINC
3938
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $180K | ﹤0.01% |
12,540
+1,001
| +9% | +$14.3K |
|
|
ABVX
3939
Abivax
ABVX
$6.72B
| $179K | ﹤0.01% |
15,572
+1,183
| +8% | +$13.6K |
|
|
TTOO
3940
DELISTED
T2 Biosystems, Inc
TTOO
| $179K | ﹤0.01% |
90,880
-39,509
| -30% | -$77.9K |
|
3941
Beasley Broadcasting Group
BBGI
$8.48M
| $177K | ﹤0.01% |
16,493
-2,226
| -12% | -$24K |
|
3942
LGL Group
LGL
$35.8M
| $176K | ﹤0.01% |
28,717
+2,597
| +10% | +$15.9K |
|
3943
Clean Energy Technologies
CETY
$16.4M
| $176K | ﹤0.01% |
175,673
+28,818
| +20% | +$28.8K |
|
3944
Odyssey Marine Exploration
OMEX
$76.4M
| $175K | ﹤0.01% |
211,496
+2,269
| +1% | +$1.88K |
|
3945
NeueHealth
NEUE
$61.8M
| $175K | ﹤0.01% |
33,447
+971
| +3% | +$5.07K |
|
|
AIFF
3946
Firefly Neuroscience, Inc. Common Stock
AIFF
$35.8M
| $174K | ﹤0.01% |
57,358
+53,472
| +1,376% | +$163K |
|
3947
Lucid Diagnostics
LUCD
$126M
| $174K | ﹤0.01% |
213,540
+9,185
| +4% | +$7.49K |
|
3948
DallasNews
DALN
$79.2M
| $173K | ﹤0.01% |
41,370
-14,183
| -26% | -$59.4K |
|
3949
AudioCodes
AUDC
$276M
| $173K | ﹤0.01% |
17,801
| – | – |
|
3950
KORE Group Holdings
KORE
$39.9M
| $173K | ﹤0.01% |
76,480
-4,515
| -6% | -$10.2K |
|